Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor

OBJECTIVE: To describe the efficacy, superiority and safety profile of the first-in-class angiotensin receptor-neprilysin inhibitor “Sacubitril/Valsartan” as compared to angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blocker (ARB) in heart failure (HF) patients, reviewin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dargad, Ramesh R., Prajapati, Mahesh R., Dargad, Rohit R., Parekh, Jai D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097164/
https://www.ncbi.nlm.nih.gov/pubmed/30122239
http://dx.doi.org/10.1016/j.ihj.2018.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097164/
https://www.ncbi.nlm.nih.gov/pubmed/30122239
http://dx.doi.org/10.1016/j.ihj.2018.01.002

Ejemplares similares